Related Experiment Videos
Pharmacokinetics of phenprocoumon
1Department of Clinical Pharmacology, Medizinische Hochschule Erfurt, Germany.
Summary
Phenprocoumon (PPC) shows rapid initial elimination after intravenous injection, likely due to enhanced renal and hepatic clearance. Oral absorption of PPC is nearly complete, with similar elimination phases observed between administration routes.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Drug Metabolism
Background:
- Phenprocoumon (PPC) is an anticoagulant medication.
- Understanding PPC pharmacokinetics is crucial for safe and effective therapeutic use.
- Variations in drug absorption and elimination can impact patient outcomes.
Purpose of the Study:
- To investigate the pharmacokinetics of phenprocoumon (PPC) in healthy volunteers.
- To compare plasma levels and clearance after intravenous (i.v.) and oral administration.
- To evaluate the absorption and elimination characteristics of PPC.
Main Methods:
- Intraindividual comparison of plasma concentrations after i.v. and oral PPC administration.
- Measurement of urinary excretion and plasma concentration to determine total plasma clearance.
- Analysis of pharmacokinetic parameters including half-life, Cmax, Tmax, and AUC.
Main Results:
- Higher initial plasma concentrations and steeper decline observed after i.v. PPC compared to oral.
- Mean PPC clearance was 20.0 ml/h (i.v.) and 15.1 ml/h (oral) within the first 8 hours.
- Elimination phases showed no significant difference between i.v. and oral administration.
- Nearly complete absorption of oral PPC from the tablet formulation was suggested.
Conclusions:
- Initial rapid decline in plasma levels post-i.v. PPC suggests enhanced renal and hepatic elimination.
- Oral administration of PPC results in nearly complete absorption.
- Pharmacokinetic profiles indicate comparable elimination phases regardless of administration route after initial distribution.